|
MUMBAI - Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN,
NSE: SUN PHARMA, BSE: 524715) today announced its subsidiary, Alkaloida
Chemical Company Exclusive Group Ltd. (Alkaloida), has extended the
Expiration Date of the Tender Offer for the purchase of all outstanding
Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro). The Offer will
now expire at 5:00 p.m., New York City time, on Friday, April 3, 2009, unless
further extended or earlier terminated. The Tender Offer was extended to
comply with a continuing order issued by the Supreme Court of Israel
temporarily prohibiting the closing of the Offer until the Supreme Court
issues a decision on the appeal of the litigation commenced against Alkaloida
and its affiliates by Taro and certain of its directors regarding the
applicability of the special tender offer rules under the Israeli Companies
Law to the Offer. The Tel-Aviv District Court had previously ruled in favor
of Sun that a special tender offer was not required.
MUMBAI, India - Egged on by factors such as strong consumer demand for enhanced safety
features, the need for compliance with emission regulations, and original
equipment manufacturers’ (OEMs) commitment to introduce novel products, the
automotive electronic control units (ECUs) market in India is witnessing
steady growth. Comfort and convenience top the agenda for customers,
triggering growth especially in the body control and steering systems
segment. Emission norms and safety regulations will further drive the uptake
of ECUs.
MUMBAI, India - Subsidiary, TCTS, Receive Contract for Network Operation and Management
of SEACOM Cable
|
|
